Paracetamol (acetaminophen) hypersensitivity. 1997

C Vidal, and C Pérez-Carral, and A González-Quintela
Division of Allergy, Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain.

BACKGROUND Paracetamol (acetaminophen) intolerance can occur in less than 5% of aspirin-sensitive subjects as a result of inhibition of prostaglandin synthesis but hypersensitivity to paracetamol without aspirin sensitivity is rare. METHODS We report a case of an acute life-threatening hypersensitivity reaction to paracetamol. RESULTS An oral challenge with 125 mg of paracetamol was carried out and followed by generalized anaphylactic reaction. An oral provocation test with 500 mg aspirin was well tolerated in the patient. CONCLUSIONS An acute hypersensitivity reaction to paracetamol is described in this study. The results of the study suggest a real allergic mechanism rather than inhibition of prostaglandin synthesis as responsible.

UI MeSH Term Description Entries
D007073 Immunoglobulin E An immunoglobulin associated with MAST CELLS. Overexpression has been associated with allergic hypersensitivity (HYPERSENSITIVITY, IMMEDIATE). IgE
D004342 Drug Hypersensitivity Immunologically mediated adverse reactions to medicinal substances used legally or illegally. Allergy, Drug,Hypersensitivity, Drug,Drug Allergy,Allergies, Drug,Drug Allergies,Drug Hypersensitivities,Hypersensitivities, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000082 Acetaminophen Analgesic antipyretic derivative of acetanilide. It has weak anti-inflammatory properties and is used as a common analgesic, but may cause liver, blood cell, and kidney damage. Acetamidophenol,Hydroxyacetanilide,Paracetamol,APAP,Acamol,Acephen,Acetaco,Acetominophen,Algotropyl,Anacin-3,Datril,N-(4-Hydroxyphenyl)acetanilide,N-Acetyl-p-aminophenol,Panadol,Tylenol,p-Acetamidophenol,p-Hydroxyacetanilide,Anacin 3,Anacin3
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000888 Antibodies, Anti-Idiotypic Antibodies which react with the individual structural determinants (idiotopes) on the variable region of other antibodies. Anti-Antibodies,Anti-Idiotype Antibodies,Antibodies, Internal Image,Antigamma Globulin Antibodies,Antiglobulins,Anti Antibodies,Anti-gamma Globulin Antibodies,Anti Idiotype Antibodies,Anti gamma Globulin Antibodies,Anti-Idiotypic Antibodies,Antibodies, Anti,Antibodies, Anti Idiotypic,Antibodies, Anti-Idiotype,Antibodies, Anti-gamma Globulin,Antibodies, Antigamma Globulin,Globulin Antibodies, Anti-gamma,Globulin Antibodies, Antigamma,Image Antibodies, Internal,Internal Image Antibodies
D000939 Epitopes Sites on an antigen that interact with specific antibodies. Antigenic Determinant,Antigenic Determinants,Antigenic Specificity,Epitope,Determinant, Antigenic,Determinants, Antigenic,Specificity, Antigenic
D016861 Cyclooxygenase Inhibitors Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes. Cyclo-Oxygenase Inhibitor,Cyclooxygenase Inhibitor,Prostaglandin Endoperoxide Synthase Inhibitor,Prostaglandin Endoperoxide Synthase Inhibitors,Prostaglandin Synthase Inhibitor,Prostaglandin Synthase Inhibitors,Prostaglandin Synthesis Antagonist,Prostaglandin Synthesis Antagonists,Cyclo-Oxygenase Inhibitors,Inhibitors, Cyclo-Oxygenase,Inhibitors, Cyclooxygenase,Inhibitors, Prostaglandin Synthase,Inhibitors, Prostaglandin-Endoperoxide Synthase,Antagonist, Prostaglandin Synthesis,Antagonists, Prostaglandin Synthesis,Cyclo Oxygenase Inhibitor,Cyclo Oxygenase Inhibitors,Inhibitor, Cyclo-Oxygenase,Inhibitor, Cyclooxygenase,Inhibitor, Prostaglandin Synthase,Inhibitors, Cyclo Oxygenase,Inhibitors, Prostaglandin Endoperoxide Synthase,Synthase Inhibitor, Prostaglandin,Synthesis Antagonist, Prostaglandin
D018712 Analgesics, Non-Narcotic A subclass of analgesic agents that typically do not bind to OPIOID RECEPTORS and are not addictive. Many non-narcotic analgesics are offered as NONPRESCRIPTION DRUGS. Non Opioid Analgesic,Non-Opioid Analgesic,Nonopioid Analgesic,Nonopioid Analgesics,Analgesics, Nonnarcotic,Analgesics, Nonopioid,Non-Opioid Analgesics,Analgesic, Non Opioid,Analgesic, Non-Opioid,Analgesic, Nonopioid,Analgesics, Non Narcotic,Analgesics, Non-Opioid,Non Opioid Analgesics,Non-Narcotic Analgesics,Nonnarcotic Analgesics,Opioid Analgesic, Non

Related Publications

C Vidal, and C Pérez-Carral, and A González-Quintela
December 2000, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology,
C Vidal, and C Pérez-Carral, and A González-Quintela
February 1996, Allergy,
C Vidal, and C Pérez-Carral, and A González-Quintela
January 1990, IARC monographs on the evaluation of carcinogenic risks to humans,
C Vidal, and C Pérez-Carral, and A González-Quintela
November 2013, Journal of pain and symptom management,
C Vidal, and C Pérez-Carral, and A González-Quintela
August 2004, SADJ : journal of the South African Dental Association = tydskrif van die Suid-Afrikaanse Tandheelkundige Vereniging,
C Vidal, and C Pérez-Carral, and A González-Quintela
June 2004, Clinical evidence,
C Vidal, and C Pérez-Carral, and A González-Quintela
January 2009, Drugs,
C Vidal, and C Pérez-Carral, and A González-Quintela
February 2004, Journal of pain and symptom management,
C Vidal, and C Pérez-Carral, and A González-Quintela
October 1993, Pharmacology & therapeutics,
C Vidal, and C Pérez-Carral, and A González-Quintela
June 2002, Clinical evidence,
Copied contents to your clipboard!